Access cutting-edge pancreatic adenocarcinoma non-resectable treatment through this clinical trial at a research site in Morgantown. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Morgantown location
Preparing your pre-screening questions…
Access pancreatic adenocarcinoma non-resectable specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic adenocarcinoma non-resectable treatment provided free
Check if you qualify for this pancreatic adenocarcinoma non-resectable clinical trial in Morgantown, WV
No-Cost Study Care
Local to Morgantown
Convenient for WV residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is being done to find out if delivering gemcitabine using the ACT-IOP-003 device directly to the area where the tumor is in the pancreas is safe and tolerable. The main questions the study aims to answer are: * Is ACT-IOP-003 safe and tolerable when given to patients with nonmetastatic, locally advanced, nonresectable pancreatic cancer. * How much study drug (gemcitabine) is found in the blood before and after treatment. * If the tumor responds to treatment. * If the gemcitabine side effects are less than seen when delivered intravenously (IV). Study participants will: * Have the study device surgically placed on the pancreas at the beginning of the study. * Complete 8 weeks of treatment with a 4 week screening period and 12 weeks of follow-up for a total of 24 weeks of participation in the study. * Give blood, urine, and stool samples to monitor safety and determine how much of the study drug (gemcitabine) is in the blood. * Have imaging (CT) done at least three times during the study.
Sponsor: Continuity Biosciences, LLC
Yes, this clinical trial (NCT07481383) has an active research site in Morgantown, WV that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pancreatic adenocarcinoma non-resectable treatment options in Morgantown, WV, this clinical trial (NCT07481383) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Morgantown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic adenocarcinoma non-resectable specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pancreatic adenocarcinoma non-resectable clinical trials near you to find additional studies recruiting in your area.
See all pancreatic cancer clinical trials recruiting in Morgantown — not just this study.
Browse Pancreatic Cancer Trials in Morgantown →